HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels

Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx. Laura suggests that manufacturers must move beyond payer-centric models toward integrated, direct-to-consumer and employer channel strategies that connect pricing, demand, and fulfillment. Sh

By Drug Channels · Apr 24, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels

Tags
negotiationsformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Negotiations
All Negotiations →
NegotiationsDrug Channels ↗
Here at Drug Channels, we’ve been closely tracking the evolution of the pharmacy benefit management (PBM) indu…
May 20, 2026
Amgen expands crackdown on what it says is misuse of 340B program
NegotiationsEndpoints News ↗
Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal dru…
May 15, 2026
Optum Rx unveils pharmacy model with clear fees, building on transparency push
NegotiationsEndpoints News ↗
UnitedHealth Group’s Optum Rx on Monday unveiled a new approach to prescription drug benefits that it said off…
May 11, 2026